Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Completed
- Conditions
- New StrategiesGINA 2006Patient Opinion
- Registration Number
- NCT00695357
- Lead Sponsor
- AstraZeneca
- Brief Summary
Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 832
Inclusion Criteria
- Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
- Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study
Read More
Exclusion Criteria
- Patients who are not willing to sign the Informed Consent Form
- COPD Patients
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage (%) of Asthma treatment satisfaction and control grading single visit / once
- Secondary Outcome Measures
Name Time Method Rate of treatment compliance single visit / once Patients quality of life under treatment single visit / once
Trial Locations
- Locations (1)
Research Site
🇬🇷Xalkida, Greece